Issue 12, 2012

Emac – a comparative index for the assessment of macrocyclization efficiency

Abstract

Macrocycle-based drug design represents an exciting new frontier in drug discovery, and consequently there is considerable interest in methodologies for the efficient construction of macrocyclic motifs. However, typical high-dilution macrocyclization conditions are inefficient and impractical in a pharmaceutical setting from cost, capacity and green chemistry perspectives. This critical review reports the results of a comprehensive literature survey of recent macrocyclization reactions and proposes a macrocyclization efficiency index, Emac, which takes into account both reaction yield and concentration. Analysis and discussion of the literature dataset using this novel metric are presented, along with selected examples of high and low efficiency macrocyclizations.

Graphical abstract: Emac – a comparative index for the assessment of macrocyclization efficiency

Supplementary files

Article information

Article type
Review Article
Submitted
30 Jun 2012
Accepted
24 Aug 2012
First published
29 Aug 2012

Med. Chem. Commun., 2012,3, 1489-1495

Emac – a comparative index for the assessment of macrocyclization efficiency

J. C. Collins and K. James, Med. Chem. Commun., 2012, 3, 1489 DOI: 10.1039/C2MD20176C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements